This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Pregnancy
+2

Study of Betatrophin Levels in Patients With Type 2 Diabetes and Gestational Diabetes and Healthy Subjects

Sponsored by Qingdao University

About this trial

Last updated 11 years ago

Study ID

Betatrophin-Human

Status

Unknown status

Type

Observational

Placebo

No

Accepting

18-75 Years
20+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 11 years ago

What is this trial about?

Betatrophin is a newly identified hormone that promotes pancreatic beta cell proliferation, improves glucose tolerance and regulates lipids metabolism. A recent study showed that circulating concentrations of betatrophin doubled in type 1 diabetes. The objective of this study is to investigate the association of serum betatrophin levels with the progression of diabetic retinopathy in patients with type 2 diabetes and the level of betatrophin in gestational diabetes patients and pregnant women.

What are the participation requirements?

Yes

Inclusion Criteria

- Type 2 diabetes mellitus patients

- Patients with HbA1c >or= 7.0%

No

Exclusion Criteria

- Participation in other investigational Clinical Trial

- Type 1 diabetes mellitus patients

- Patients with history of severe hepatic dysfunction

- Treatment with antifungal agent especially Miconazole

- Patients with active smoking or history of smoking cessation less than 2 months